Advances in MRI biomarkers for the diagnosis of Alzheimer's disease
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Yn: Biomarkers in Medicine, Cyfrol 8, Rhif 9, 01.10.2014, t. 1151-69.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Advances in MRI biomarkers for the diagnosis of Alzheimer's disease
AU - Kehoe, Elizabeth G
AU - McNulty, Jonathan P
AU - Mullins, Paul G
AU - Bokde, Arun L W
PY - 2014/10/1
Y1 - 2014/10/1
N2 - With the prevalence of Alzheimer's disease (AD) predicted to increase substantially over the coming decades, the development of effective biomarkers for the early detection of the disease is paramount. In this short review, the main neuroimaging techniques which have shown potential as biomarkers for AD are introduced, with a focus on MRI. Structural MRI measures of the hippocampus and medial temporal lobe are still the most clinically validated biomarkers for AD, but newer techniques such as functional MRI and diffusion tensor imaging offer great scope in tracking changes in the brain, particularly in functional and structural connectivity, which may precede gray matter atrophy. These new advances in neuroimaging methods require further development and crucially, standardization; however, before they are used as biomarkers to aid in the diagnosis of AD.
AB - With the prevalence of Alzheimer's disease (AD) predicted to increase substantially over the coming decades, the development of effective biomarkers for the early detection of the disease is paramount. In this short review, the main neuroimaging techniques which have shown potential as biomarkers for AD are introduced, with a focus on MRI. Structural MRI measures of the hippocampus and medial temporal lobe are still the most clinically validated biomarkers for AD, but newer techniques such as functional MRI and diffusion tensor imaging offer great scope in tracking changes in the brain, particularly in functional and structural connectivity, which may precede gray matter atrophy. These new advances in neuroimaging methods require further development and crucially, standardization; however, before they are used as biomarkers to aid in the diagnosis of AD.
KW - Alzheimer Disease
KW - Biomarkers
KW - Functional Neuroimaging
KW - Hippocampus
KW - Humans
KW - Magnetic Resonance Imaging
KW - Temporal Lobe
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
KW - Review
U2 - 10.2217/bmm.14.42
DO - 10.2217/bmm.14.42
M3 - Article
C2 - 25402585
VL - 8
SP - 1151
EP - 1169
JO - Biomarkers in Medicine
JF - Biomarkers in Medicine
SN - 1752-0363
IS - 9
ER -